Brenntag Specialties Pharma offering phosphate-based excipients by Budenheim
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
This marks the fourth acquisition by Corona Remedies from multinational corporations
Enables additional US manufacturing capacity to serve increased demand for pharma/biotech customers
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
Friesland Campina Professional’s innovative Kievit portfolio features fat powders, creamers, foamers, whipping agents, cake emulsifiers
Azelis will strengthen its presence in the domestic market by leveraging portfolio synergies, actively consolidating the business, and creating value for all stakeholders
Subscribe To Our Newsletter & Stay Updated